Literature DB >> 4045512

Treatment of myasthenia gravis.

D P Richman.   

Abstract

Entities:  

Mesh：

Year:  1985        PMID： 4045512     DOI： 10.1007/BF00313780

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  14 in total

1.  Study of long-term anticholinesterase therapy. Effects on neuromuscular transmission and on motor end-plate fine structure.

Authors:  A G Engel; E H Lambert; T Santa
Journal:  Neurology       Date:  1973-12       Impact factor: 9.910

2.  Autoimmune response to acetylcholine receptor.

Authors:  J Patrick; J Lindstrom
Journal:  Science       Date:  1973-05-25       Impact factor: 47.728

3.  Long-term effects of repeated plasma exchange in myasthenia gravis.

Authors:  J Newsom-Davis; S G Wilson; A Vincent; C D Ward
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

4.  Effect of immunosuppressive drugs (azathioprine).

Authors:  H G Mertens; G Hertel; P Reuther; K Ricker
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

5.  The value of thymectomy in myasthenia gravis: a computer-assisted matched study.

Authors:  J M Buckingham; F M Howard; P E Bernatz; W S Payne; E G Harrison; P C O'Brien; L H Weiland
Journal:  Ann Surg       Date:  1976-10       Impact factor: 12.969

6.  Stable remissions in myasthenia gravis.

Authors:  M C Perez; W L Buot; C Mercado-Danguilan; Z G Bagabaldo; L D Renales
Journal:  Neurology       Date:  1981-01       Impact factor: 9.910

7.  The effect of anti-thymocyte antiserum in progressive myasthenia gravis.

Authors:  B Pirofsky
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

8.  Infection among 210 patients with surgically staged Hodgkin's disease.

Authors:  D D Coker; D M Morris; J J Coleman; S C Schimpff; P H Wiernik; E G Elias
Journal:  Am J Med       Date:  1983-07       Impact factor: 4.965

Review 9.  Myasthenia gravis and myasthenic syndromes.

Authors:  A G Engel
Journal:  Ann Neurol       Date:  1984-11       Impact factor: 10.422

10.  Remission of myasthenia gravis following plasma-exchange.

Authors:  A J Pinching; D K Peters
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.